Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H28FNO3S2 |
InChIKeyMEFAYSLODGHXPL-UHFFFAOYSA-N |
CAS Registry3055558-98-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 04 Dec 2024 |





